NCT05661994 - Omega-3 Supplementation on Serum Fetuin-A Levels | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

October 11, 2021

Study Completion Date

April 8, 2022

Conditions

Coronary Artery Disease

Interventions

DIETARY_SUPPLEMENT

Omega-3 fatty acid supplementation

"Patients with CAD were divided into the Omega-3 Group (n:16) and Control Group (n:18) to evaluate the effects of omega-3 FA supplementation on biochemical parameters, especially serum fetuin-A, anthropometric measurements, and nutritional status. 1.560 mg/day omega-3 FA supplementation was applied for 8 weeks to 16 participants with CAD included in the omega-3 group."

Trial Locations (1)

Unknown

Gazi University Training and Research Hospital, Ankara

All Listed Sponsors

collaborator

Gazi University

OTHER

lead

Amasya University

OTHER